CLASS ACTION ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Significant Losses From Investment In Liberty Health Sciences, Inc. (Other OTC: LHSIF) To Contact Brower Piven Before The Lead Plaintiff Deadline
STEVENSON, Md., Feb. 06, 2019 (GLOBE NEWSWIRE) -- The securities
litigation law firm of Brower Piven, A Professional Corporation,
announces that a class action lawsuit has been commenced in the
United States District Court for the Southern District of New York
on behalf of purchasers of Liberty Health Sciences, Inc. (Other
OTC: LHSIF) (“Liberty†or the “Companyâ€) securities during the
period between June 28, 2018 through December 03, 2018 inclusive
(the “Class Periodâ€). Investors who wish to become
proactively involved in the litigation have until March 08, 2019 to
seek appointment as lead plaintiff.
If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in Liberty securities during the Class Period. Members of the class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No class has yet been certified in the above action.
The complaint accuses the defendants of violations of the Securities Exchange Act of 1934 by virtue of the defendants’ failure to disclose during the Class Period that Liberty, in conjunction with Aphria Inc. (“Aphriaâ€), was involved in a scheme whereby numerous fraudulent acquisitions and transactions were made to provide undue benefits to both companies’ insiders.
According to the complaint, following a December 3, 2018 report that Aphria was involved in the acquisition of shell companies at artificially inflated prices, and December 6, 2018 news reports of Liberty’s connection to Aphria’s illicit dealings, the value of Liberty shares declined significantly.
If you have suffered a loss in excess of $100,000 from investment in Liberty securities purchased on or after June 28, 2018 and held through the revelation of negative information during and/or at the end of the Class Period and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, without cost or obligation to you, please contact Brower Piven either by email at [email protected] or by telephone at (410) 415-6616.
Attorneys at Brower Piven have extensive experience in litigating securities and other class action cases and have been advocating for the rights of shareholders since the 1980s. If you choose to retain counsel, you may retain Brower Piven without financial obligation or cost to you, or you may retain other counsel of your choice. You need take no action at this time to be a member of the class.
CONTACT: Charles J. Piven
Brower Piven, A Professional Corporation
1925 Old Valley Road
Stevenson, Maryland 21153
Telephone: 410-415-6616
[email protected]